China National Pharmaceutical Group Co Ltd (Sinopharm) boasts nearly 30 core manufacturing enterprises, including Shanghai Shyndec Pharmaceutical Co Ltd and Southwest Pharmaceutical Co Ltd.

It operates China’s leading production bases for antibiotic pharmaceutical intermediates and active pharmaceutical ingredients (APIs), with its clavulanate potassium series and key intermediates for the synthesis of penicillin and cephalosporin APIs (7-ACA and 6-APA) ranking among the top nationwide in terms of production capacity and sales.

The company has also established a well-developed distribution system for anesthetic and psychotropic substances, and built integrated production bases covering the entire manufacturing process from APIs to finished dosage forms, with a full range of formulations for anesthetic and psychotropic drugs.